about
Meprins process matrix metalloproteinase-9 (MMP-9)/gelatinase B and enhance the activation kinetics by MMP-3Insufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout miceSide-by-side secretion of Late Palaeozoic diverged courtship pheromones in an aquatic salamander"Reverse degradomics", monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products.Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.Interference with glycosaminoglycan-chemokine interactions with a probe to alter leukocyte recruitment and inflammation in vivo.Zymography methods for visualizing hydrolytic enzymes.Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.Interphotoreceptor retinoid-binding protein as biomarker in systemic autoimmunity with eye inflictionsDifferential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative studyRemnant epitopes, autoimmunity and glycosylation.Functional links between gelatinase B/matrix metalloproteinase-9 and prominin-1/CD133 in diabetic retinal vasculopathy and neuropathy.Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B.Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels.A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains.Multi-chaperone complexes regulate the folding of interferon-gamma in the endoplasmic reticulum.Cross-linking approach to affinity capture of protein complexes from chaotrope-solubilized cell lysates.Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1.Improved methods for haemozoin quantification in tissues yield organ-and parasite-specific information in malaria-infected mice.Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin.CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines.Myeloid cells are tunable by a polyanionic polysaccharide derivative and co-determine host rescue from lethal virus infection.Protein disulfide isomerase-mediated cell-free assembly of recombinant interleukin-12 p40 homodimers.Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis.GroEL/ES chaperonins protect interferon-gamma against physicochemical stress--study of tertiary structure formation by alpha-casein quenching and ELISA.Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function.The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substratesThe activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhageOligosaccharides of recombinant mouse gelatinase B variantsDeficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune diseaseEDTA/gelatin zymography method to identify C1s versus activated MMP-9 in plasma and immune complexes of patients with systemic lupus erythematosusChronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gammaOpposing effects of cyclosporin A and anti-interferon-gamma antibodies on immune tolerance mechanismsStructural immuno-analysis of human and porcine interferon gamma: identification of shared antigenic domainThe Biological Potential Hidden in Inclusion BodiesHighly Selective and Tunable Protein Hydrolysis by a Polyoxometalate Complex in Surfactant Solutions: A Step toward the Development of Artificial Metalloproteases for Membrane ProteinsSTAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters
P50
Q24302283-E6079B11-DA0A-4C40-BD42-F83258953670Q27313841-8256218E-1BE8-4A0A-BD75-DF3005EAB060Q28653112-DCE8C994-453B-4C89-BDAC-E056D57F4270Q33484792-CA5AE597-A747-430B-B891-C6CE2415C2DFQ33602959-5FB580A4-2B80-4A6E-8881-877946561CFBQ34004904-4DF51593-A755-4F9A-8F91-6133CDFCBCA5Q34329995-F2413087-28FF-42BE-B047-B1E1AB91EA53Q35447969-724BAB6D-9F97-40E8-866E-F5B620FFE520Q35886714-304C9969-E005-47E0-A3ED-A6476A2657C8Q36331820-53E18222-A9FF-4894-AD4D-3DB5CBE3CB94Q36378459-1C3E08FF-D183-4991-B6DE-C751BDA32F1BQ38235675-C32239CE-520B-4182-8F99-473D9862E512Q39586822-D1F80F72-FF45-4542-8288-ECD64734CC1EQ40182997-8D848D66-1CC6-4703-9C58-917BA1FB64CDQ40264843-74CB9912-64A0-4508-B87C-BF6D7BA792A4Q40482547-C391D441-04EE-42E6-955F-89631491FE3CQ40610999-0E2BB5B7-96D5-49F8-AE6C-B7FF2321C0B9Q42030553-32B1EA12-3077-4ABE-8809-4743E34653F1Q42368319-569965B3-A314-4110-9C26-C26B14853544Q42421283-F1E20D91-D865-4F2C-93B1-AABD5132A5DEQ44355278-26E698C0-D90F-48E7-A567-DEEE6877E1C8Q44872532-AF807BDB-6BEF-4412-B7D1-CDABBB044D48Q45373708-9178A470-04A9-4302-BC2A-AA21122F9536Q50335934-AB74C1D8-0D77-4CF1-A4B4-1597BCD402CDQ52980623-381EE51C-22B2-48CC-BBB8-62F7B6E5F844Q54145583-44E4657D-9C3B-49D9-AF1A-DECA5232DF62Q54346279-C8543F43-8E84-4153-BFD1-795B81E1BCB1Q54585384-11F566C0-5CDA-4D77-A0E6-E95C8E185D60Q57584276-634444E6-AAB9-47F9-9FC8-56437C3DF211Q57584366-6A200C01-E60A-48A3-9C89-F0D5DA64D5B7Q57584697-53E412D9-6C84-4EAB-A864-14BF780F7181Q57585388-EFD509BE-463B-4DD5-AFDF-5C5E0DBA4783Q57792121-DCEA33E8-8560-44C8-8ADD-22FDE2688AD3Q71740175-25E1F47A-E003-435E-AED8-9770E3F6944AQ73278707-FE1C55A1-022F-4D0E-B456-04775651F20AQ73561393-87149136-C8CB-4FD5-87FC-716B9C701EC5Q89783436-A097E36F-5410-47D8-B1CB-83F52D4165A2Q90333265-F0B1CC6B-B3EB-43D2-B2F3-ABBB7E24A002Q95605613-71CDB796-0034-4A01-8D25-74213CD7BB3B
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-7947-6567
@en
name
Erik Martens
@ast
Erik Martens
@en
Erik Martens
@es
Erik Martens
@nl
type
label
Erik Martens
@ast
Erik Martens
@en
Erik Martens
@es
Erik Martens
@nl
prefLabel
Erik Martens
@ast
Erik Martens
@en
Erik Martens
@es
Erik Martens
@nl
P106
P31
P496
0000-0002-7947-6567